Inotiv, Inc. (NOTV)

2.1100

+0.1500

+(7.63%)

As of 3:28:30 PM EDT. Market Open.

Inotiv Second Quarter 2025 Earnings: EPS Beats Expectations

Inotiv ( NASDAQ:NOTV ) Second Quarter 2025 Results Key Financial Results Revenue: US$124.3m (up 4.4% from 2Q 2024). Net...

Simply Wall St. 2 days ago

NOTV
+7.63%
Inotiv Inc (NOTV) Q2 2025 Earnings Call Highlights: Revenue Growth and Strategic Optimizations ...

Inotiv Inc (NOTV) reports a 4.4% revenue increase and strategic site optimizations, despite facing profitability challenges and market uncertainties.

GuruFocus.com 4 days ago

NOTV
+7.63%
Inotiv, Inc. (NOTV) Reports Q2 Loss, Tops Revenue Estimates

Inotiv (NOTV) delivered earnings and revenue surprises of 25% and 3.41%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Zacks 4 days ago

NOTV
+7.63%
Inotiv Reports Second Quarter Financial Results for Fiscal 2025 and Provides Business Update

— Second quarter fiscal 2025 revenue increased 4.4% to $124.3 million— Year-to-date fiscal 2025 revenue declined 4.1% to $244.2 million— Conference call scheduled for today at 4:30 pm ET WEST LAFAYETTE, Ind., May 07, 2025 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, today announced financial results

GlobeNewswire 4 days ago

NOTV
+7.63%
Will Nektar Therapeutics (NKTR) Report Negative Q1 Earnings? What You Should Know

Nektar (NKTR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks 11 days ago

NKTR

NOTV
+7.63%
Inotiv, Inc. (NOTV) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Inotiv (NOTV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks 12 days ago

NOTV
+7.63%

BCRX
Inotiv, Inc. to Report Fiscal 2025 Second Quarter Financial Results and Host Conference Call on Wednesday, May 7, 2025

WEST LAFAYETTE, Ind., April 23, 2025 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, today announced that it will issue its financial results for the fiscal 2025 second quarter ended March 31, 2025, on Wednesday, May 7, 2025, after the close of the stock market. The Company will host a conf

GlobeNewswire 18 days ago

NOTV
+7.63%
Sea Pharmaceuticals Announces Strategic Relationship to Advance Treatments For Patients with CNS Disorders

Sea's pre-clinical stage neurotherapeutic synthetic oral molecules act at the neurotransmitter glutamate pathway on two clinically validated targets in the CNS (central nervous system) Sea's lead molecule SPM-0404 is a potential new oral treatment ...

ACCESS Newswire last month

NOTV
+7.63%
Inotiv (NASDAQ:NOTV investor three-year losses grow to 88% as the stock sheds US$46m this past week

Every investor on earth makes bad calls sometimes. But you want to avoid the really big losses like the plague. So take...

Simply Wall St. 2 months ago

NOTV
+7.63%
Inotiv Inc (NOTV) Q1 2025 Earnings Call Highlights: Navigating Challenges with Strategic Growth ...

Despite a revenue dip, Inotiv Inc (NOTV) focuses on liquidity improvement, client base expansion, and strategic investments for future growth.

GuruFocus.com 3 months ago

NOTV
+7.63%
Inotiv Reports First Quarter Financial Results for Fiscal 2025 and Provides Business Update

Enhanced liquidity by $27.5 million through the issuance of 6.9 million common sharesFirst quarter fiscal 2025 revenue declined 11.5% to $119.9 millionConference call scheduled for today at 4:30 pm ET WEST LAFAYETTE, Ind., Feb. 05, 2025 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, today announced fin

GlobeNewswire 3 months ago

NOTV
+7.63%
Inotiv, Inc. to Report Fiscal 2025 First Quarter Financial Results and Host Conference Call on Wednesday, February 5, 2025

WEST LAFAYETTE, Ind., Jan. 22, 2025 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, today announced that it will issue its financial results for the fiscal 2025 first quarter ended December 31, 2024, on Wednesday, February 5, 2025, after the close of the stock market. The Company will host

GlobeNewswire 3 months ago

NOTV
+7.63%
Inotiv, Inc. Completes Equity Offering for Net Proceeds of Approximately $3.6 Million

WEST LAFAYETTE, Ind., Dec. 30, 2024 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, today announced that it had raised an additional $3.6 million in net proceeds from the optional shares in connection with its previously announced underwritten public offering of common shares. The Company issued the add

GlobeNewswire 4 months ago

NOTV
+7.63%
Inotiv, Inc. Completes Equity Offering for Net Proceeds of Approximately $24.0 Million

WEST LAFAYETTE, Ind., Dec. 23, 2024 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, today announced that it had raised approximately $24.0 million in net proceeds from its underwritten public offering of 6,000,000 common shares at a price to the public of $4.25 per share. All the shares were offered and

GlobeNewswire 4 months ago

NOTV
+7.63%
Inotiv, Inc. Announces Pricing of Public Offering of 6,000,000 Common Shares

WEST LAFAYETTE, Ind., Dec. 18, 2024 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, today announced the pricing of its underwritten public offering of 6,000,000 common shares at a price to the public of $4.25 per share. In addition, the Company has granted the underwriter a 30-day option to purchase up

GlobeNewswire 4 months ago

NOTV
+7.63%
Inotiv, Inc. Launches Proposed Public Offering of Common Shares

WEST LAFAYETTE, Ind., Dec. 17, 2024 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, today announced commencement of a proposed underwritten public offering of its common shares. All the shares will be offered by the Company. The Company also expects to grant the underwriters a 30-day option to purchase

GlobeNewswire 4 months ago

NOTV
+7.63%
Inotiv Inc (NOTV) Q4 2024 Earnings Call Highlights: Revenue Growth Amid Operational Challenges

Inotiv Inc (NOTV) reports a 23% quarter-over-quarter revenue increase despite facing a net loss and pricing pressures.

GuruFocus.com 5 months ago

NOTV
+7.63%
Inotiv Reports Fourth Quarter and Full Year Financial Results for Fiscal 2024 and Provides Business Update

— Enhanced liquidity through issuance of Second Lien Notes — Obtained amendment to credit agreement and extended note payable — Fourth quarter fiscal 2024 revenue down 7.3% to $130.4 million — Full year fiscal 2024 revenue down 14.3% to $490.7 million — Conference call begins today at 4:30 pm ET WEST LAFAYETTE, Ind., Dec. 03, 2024 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company”), a leading contract research organization specializing in nonclinical and analytical drug discovery and

GlobeNewswire 5 months ago

NOTV
+7.63%
Inotiv Ranked Number 138 Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500™

Acquiring and Developing Services and Resources to Build a Full Service, Customer-Focused CRO has Fueled 847% Revenue GrowthWEST LAFAYETTE, Ind., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Inotiv today announced it ranked 138 on the Deloitte Technology Fast 500™, a ranking of the 500 fastest-growing technology, media, telecommunications, life sciences, fintech, and energy tech companies in North America. Over the last five years Inotiv grew 847%. Inotiv’s president and chief executive officer, Robert Lea

GlobeNewswire 5 months ago

NOTV
+7.63%
Inotiv, Inc. to Report Fiscal 2024 Fourth Quarter and Full Year Results and Host Conference Call on Tuesday, December 3, 2024

WEST LAFAYETTE, Ind., Nov. 20, 2024 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company” or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, today announced that it will issue its financial results for the fiscal 2024 fourth quarter and full year ended September 30, 2024, on Tuesday, December 3, 2024, after the close of the stock market. The Compa

GlobeNewswire 5 months ago

NOTV
+7.63%

Performance Overview

Return	NOTV	S&P 500 (^GSPC)
YTD	-49.03%	-0.85%
1-Year	-43.88%	+11.66%
3-Year	-82.36%	+48.39%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

TARIFFS LATEST

Inotiv, Inc. (NOTV)

Inotiv Second Quarter 2025 Earnings: EPS Beats Expectations

Inotiv Inc (NOTV) Q2 2025 Earnings Call Highlights: Revenue Growth and Strategic Optimizations ...

Inotiv, Inc. (NOTV) Reports Q2 Loss, Tops Revenue Estimates

Inotiv Reports Second Quarter Financial Results for Fiscal 2025 and Provides Business Update

Will Nektar Therapeutics (NKTR) Report Negative Q1 Earnings? What You Should Know

Inotiv, Inc. (NOTV) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Inotiv, Inc. to Report Fiscal 2025 Second Quarter Financial Results and Host Conference Call on Wednesday, May 7, 2025

Sea Pharmaceuticals Announces Strategic Relationship to Advance Treatments For Patients with CNS Disorders

Inotiv (NASDAQ:NOTV investor three-year losses grow to 88% as the stock sheds US$46m this past week

Inotiv Inc (NOTV) Q1 2025 Earnings Call Highlights: Navigating Challenges with Strategic Growth ...

Inotiv Reports First Quarter Financial Results for Fiscal 2025 and Provides Business Update

Inotiv, Inc. to Report Fiscal 2025 First Quarter Financial Results and Host Conference Call on Wednesday, February 5, 2025

Inotiv, Inc. Completes Equity Offering for Net Proceeds of Approximately $3.6 Million

Inotiv, Inc. Completes Equity Offering for Net Proceeds of Approximately $24.0 Million

Inotiv, Inc. Announces Pricing of Public Offering of 6,000,000 Common Shares

Inotiv, Inc. Launches Proposed Public Offering of Common Shares

Inotiv Inc (NOTV) Q4 2024 Earnings Call Highlights: Revenue Growth Amid Operational Challenges

Inotiv Reports Fourth Quarter and Full Year Financial Results for Fiscal 2024 and Provides Business Update

Inotiv Ranked Number 138 Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500™

Inotiv, Inc. to Report Fiscal 2024 Fourth Quarter and Full Year Results and Host Conference Call on Tuesday, December 3, 2024

Performance Overview